Access to care” emerged as a top healthcare C-suite buzzword heading into 2025. While much of the conversation has focused on coverage, affordability and capacity, hospital and health system leaders ...

By going with the 12-month package, you're going to see the best results when it comes to discounts, with the 4GB plan coming ...

Phase 1 dose escalation study expected in 3Q 2026 Cash balance of $38.8 million as of September 30, 2025 anticipated to fund key milestones into 2027 REDWOOD CITY, Calif., Nov. 12, 2025 (GLOBE ...

Aethlon Medical, Inc. (the Company or Aethlon) (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today reported ...